Ovid Therapeutics Unearned Premium on Insurance Contract (Quarterly) Insights

Ovid Therapeutics, Inc. (OVID)

1.63 +0.12 (+7.95%) USD | NASDAQ | Feb 25, 16:00

1.68 +0.05 (+3.07%) After-Hours: 20:00

View Unearned Premium on Insurance Contract (Quarterly) for OVID.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

Cassava Sciences, Inc.	--
PTC Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--